General Information of Drug Off-Target (DOT) (ID: OTYWPPM3)

DOT Name Tachykinin-4 (TAC4)
Synonyms Preprotachykinin-C; PPT-C
Gene Name TAC4
Related Disease
Crohn disease ( )
Inflammatory bowel disease ( )
Multiple sclerosis ( )
Familial cold autoinflammatory syndrome ( )
Fibromyalgia ( )
Hepatitis B virus infection ( )
Nasal polyp ( )
Uterine fibroids ( )
Asthma ( )
Astrocytoma ( )
Glioma ( )
Melanoma ( )
Neoplasm ( )
Osteoarthritis ( )
Rheumatoid arthritis ( )
UniProt ID
TKN4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2MOC
Sequence
MLPCLALLLLMELSVCTVAGDGGEEQTLSTEAETWVIVALEEGAGPSIQLQLQEVKTGKA
SQFFGLMGKRVGGRPLIQPRRKKAYQLEHTFQGLLGKRSLFTEGREDEAQGSE
Function
Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. Endokinin-A induces thermal hyperalgesia and pain-related behavior such as scratching following intrathecal administration in rats. These effects are suppressed by treatment with endokinin-C. Endokinin-A/B reduces arterial blood pressure and increases sperm motility.
Tissue Specificity
Expressed at low levels in the uterus of both pregnant and non-pregnant women. Isoform 1 is found only in the adrenal gland and fetal liver. Isoform 2 is found in heart, liver, bone marrow, prostate, adrenal gland and testis. Isoform 3 and isoform 4 are expressed predominantly in adrenal gland and placenta.
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )

Molecular Interaction Atlas (MIA) of This DOT

15 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Crohn disease DIS2C5Q8 Definitive Altered Expression [1]
Inflammatory bowel disease DISGN23E Definitive Biomarker [1]
Multiple sclerosis DISB2WZI Definitive Genetic Variation [2]
Familial cold autoinflammatory syndrome DISAPE70 Strong Biomarker [3]
Fibromyalgia DISZJDS2 Strong Biomarker [4]
Hepatitis B virus infection DISLQ2XY Strong Biomarker [5]
Nasal polyp DISLP3XE Strong Altered Expression [6]
Uterine fibroids DISBZRMJ Strong Biomarker [7]
Asthma DISW9QNS Limited Biomarker [8]
Astrocytoma DISL3V18 Limited Biomarker [9]
Glioma DIS5RPEH Limited Biomarker [9]
Melanoma DIS1RRCY Limited Biomarker [10]
Neoplasm DISZKGEW Limited Biomarker [10]
Osteoarthritis DIS05URM Limited Altered Expression [11]
Rheumatoid arthritis DISTSB4J Limited Altered Expression [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Tachykinin-4 (TAC4). [12]
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Tachykinin-4 (TAC4). [14]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Tachykinin-4 (TAC4). [16]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Tachykinin-4 (TAC4). [13]
Quercetin DM3NC4M Approved Quercetin increases the expression of Tachykinin-4 (TAC4). [15]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Tachykinin-4 (TAC4). [17]
------------------------------------------------------------------------------------

References

1 Distinct differences in tachykinin gene expression in ulcerative colitis, Crohn's disease and diverticular disease: a role for hemokinin-1?.Neurogastroenterol Motil. 2011 May;23(5):475-83, e179-80. doi: 10.1111/j.1365-2982.2011.01685.x. Epub 2011 Feb 22.
2 The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.J Neuroimmunol. 2007 Feb;183(1-2):208-13. doi: 10.1016/j.jneuroim.2006.11.002. Epub 2006 Dec 18.
3 Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms.Brain Res Bull. 2019 Apr;147:165-173. doi: 10.1016/j.brainresbull.2019.01.015. Epub 2019 Jan 18.
4 Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome.Front Cell Neurosci. 2019 Aug 2;13:353. doi: 10.3389/fncel.2019.00353. eCollection 2019.
5 Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination.Viral Immunol. 2012 Aug;25(4):289-96. doi: 10.1089/vim.2012.0015.
6 Hemokinin-1 stimulates C-C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polyps.Int Forum Allergy Rhinol. 2019 Nov;9(11):1334-1345. doi: 10.1002/alr.22430. Epub 2019 Sep 23.
7 Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.Fertil Steril. 2016 Nov;106(6):1521-1529. doi: 10.1016/j.fertnstert.2016.07.007. Epub 2016 Jul 25.
8 Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1.Respir Res. 2018 Jan 3;19(1):1. doi: 10.1186/s12931-017-0698-3.
9 Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study.J Neuroimmunol. 2005 Jul;164(1-2):48-56. doi: 10.1016/j.jneuroim.2005.03.016.
10 Human hemokinin-1 promotes migration of melanoma cells and increases MMP-2 and MT1-MMP expression by activating tumor cell NK1 receptors.Peptides. 2016 Sep;83:8-15. doi: 10.1016/j.peptides.2016.07.004. Epub 2016 Jul 22.
11 Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis.Arthritis Res Ther. 2019 Apr 3;21(1):87. doi: 10.1186/s13075-019-1865-3.
12 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
13 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
14 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
15 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
16 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
17 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.